Experimental Cancer Drug Could Streamline Standard Tuberculosis Treatment and Prevent Post-TB Lung Disease, Study Suggests Apr. 21, 2025 — An experimental drug now in clinical trials as a cancer ...

valvular heart disease, and pulmonary hypertension. "Long COVID has emerged as a major public health challenge, and the long-term sequelae remain largely undefined," says corresponding author Maria G.

It's especially crucial for the lungs as it helps provide functional ... it isn't considered a neurological disease. However according to a 2022 study, out of 389 people suffering EDS that ...

Post-TB lung disease affects an estimated 60% of everyone who has been cured of TB. That is according to Dr Brian Allwood, a consultant pulmonologist at Stellenbosch University and Tygerberg Hospital.

The lawsuit notes that on April 1, the U.S. human services agency fired top employees including the chief medical officer overseeing the coal mine dust lung disease screening program “thus ...

Swedish pharma company Vicore has won breakthrough status from the FDA for Almee, a cognitive behavioural therapy (CBT) app used to support people with pulmonary fibrosis (PF). Almee takes the ...

Quantitative assessment of the proliferative response of bronchoalveolar mononuclear cells to specific agents is a useful diagnostic test; a well-studied example is chronic beryllium disease.

May 5, 2025 — People who are given a vaccine for shingles have a 23% lower risk of cardiovascular events, including stroke, heart failure, and coronary heart disease, according to a recent study ...

Although a wide variety of normal hair pigmentation exists, a number of specific findings may warrant further investigation. The examiner should be alert for areas of hypopigmentation as well as ...